Dr. Xavier Matias-Guiu, the new president of the International Society of Gynecological Pathologists

  • Dr. Xavier Matias-Guiu, head of the gynecological cancer research group at IDIBELL, is the new president of the International Society of Gynecological Pathologists (ISGYP) since this weekend.
NO26 - Matias-Guiu_SIPG - Imatge

ISGYP (International Society of Gynecological Pathologists) is a worldwide scientific society of pathologists with a common interest in the pathology of the female reproductive system. The Society was founded in 1976 to facilitate the exchange of knowledge on gynecological diseases and to be a forum for the dissemination of new information in this area.

Membership is open to any pathologist according to the regulations or customs of each country for specialists and who have contributed to the field of gynecological pathology.

The ISGYP is responsible at a global level to be the interlocutor for questions related to the pathology of gynecological cancers. It has a training program in gynecological pathology for pathologists around the world, with the organization of meetings jointly with the American Canadian division of the International Academy of Pathology (USCAP), the American Society of Clinical Pathology (ASCP), the Society International Gynecological Cancer (IGCS) and the European Pathology Society (ESP), among others.

This year, ISGYP has promoted virtual training through the ISGYP-life program, with four monthly sessions, which has been widely accepted in all geographical areas. ISGYP’s publication is the International Journal of Gynecological Pathology.

Among the objectives set by Dr. Matias-Guiu, group leader at IDIBELL and head of the Pathological Anatomy Service of the Bellvitge University Hospital, during the two years of his presidency are the maintenance of the virtual training program beyond the current epidemiological situation, increase the dissemination of ISGYP in all geographical areas of the world, especially in countries where it is less widely implemented, increase the relationship with associations of patients with gynecological cancer worldwide, and promote a multicenter study of global scope to provide scientific evidence to optimize endometrial cancer staging.



The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L’Hospitalet de Llobregat.

IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the “HR Excellence in Research” program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).


The International Society of Gynecological Pathologists (ISGYP)

Share on:

Scroll to Top